Connect Biopharma Holdings (CNTB) Accounts Payables (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Accounts Payables of $4.3 million for Q1 2026, up 119.25% sequentially from $2.0 million in Q4 2025, and up 427.05% YoY from $817000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Accounts Payables (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Accounts Payables for 7 years, with the latest figure at $4.3 million in Q1 2026.
- Quarterly Accounts Payables rose 427.05% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 427.05% YoY) and the FY2025 annual result came in at $2.0 million, up 474.27% from the prior year.
- Accounts Payables advanced to $4.3 million in Q1 2026 per CNTB's latest filing, from $2.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $15.1 million in Q2 2022 and troughed at $342000.0 in Q4 2024.
- A 5-year average of $5.3 million and a median of $2.3 million in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables plunged 84.52% in 2024, then jumped 474.27% in 2025.
- Over 5 years, Accounts Payables stood at $11.7 million in 2022, then sank by 81.1% to $2.2 million in 2023, then slumped by 84.52% to $342000.0 in 2024, then surged by 474.27% to $2.0 million in 2025, then soared by 119.25% to $4.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $4.3 million, $2.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Mar 31, 2026 | 4.31 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 817,000.00 |
| Dec 31, 2024 | 342,000.00 |
| Jun 30, 2024 | 5.70 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Jun 30, 2023 | 11.52 Mn |
| Dec 31, 2022 | 11.69 Mn |
| Jun 30, 2022 | 15.14 Mn |
| Dec 31, 2021 | 12.70 Mn |
| Dec 31, 2020 | 3.72 Mn |